Preventive Health & Cancer Marker Lab Panel — Comprehensive Male
The Preventive Health & Cancer Screening Support - Comprehensive Male Lab Panel includes 22 tests and 125 biomarkers to support physician-guided review of preventive wellness and selected cancer marker support labs for men. It includes CBC, CMP, FIT/InSure®, PSA free and total, AFP/AFP-L3, CEA, CA 19-9, hepatitis, liver, kidney, thyroid, iron, inflammation, urinalysis, vitamin D, lipids, glucose, cystatin C, and immune protein labs.
- $3,409.31
- $872
- Save: 74.42%
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: Microalbumin Random Urine with Creatinine
Creatinine, Random Urine
Microalbumin
Microalbumin/Creatinine
Also known as: AFP and AFP-L3%, AlphaFetoprotein AFP and AFPL3
AFP
AFP-L3
Also known as: Bilirubin Fractionated
Bilirubin, Direct
Bilirubin, Indirect
Bilirubin, Total
Also known as: CA 199, Carbohydrate Antigen 19-9
Ca 19-9
Also known as: CBC, CBC includes Differential and Platelets, CBC/PLT w/DIFF, Complete Blood Count (includes Differential and Platelets)
NOTE: Ulta Lab Tests provides CBC test results from Quest Diagnostics as they are reported. Often, different biomarker results are made available at different time intervals. When reporting the results, Ulta Lab Tests denotes those biomarkers not yet reported as 'pending' for every biomarker the test might report. Only biomarkers Quest Diagnostics observes are incorporated and represented in the final CBC test results provided by Ulta Lab Tests.
Absolute Band Neutrophils (Only Reported If Detected)
Absolute Basophils
Absolute Blasts (Only Reported If Detected)
Absolute Eosinophils
Absolute Lymphocytes
Absolute Metamyelocytes (Only Reported If Detected)
Absolute Monocytes
Absolute Myelocytes (Only Reported If Detected)
Absolute Neutrophils
Absolute Nucleated Rbc (Only Reported If Detected)
Absolute Promyelocytes (Only Reported If Detected)
Band Neutrophils (Only Reported If Detected)
Basophils
Blasts (Only Reported If Detected)
Eosinophils
Hematocrit
Hemoglobin
Lymphocytes
MCH
MCHC
MCV
Metamyelocytes (Only Reported If Detected)
Monocytes
MPV
Myelocytes (Only Reported If Detected)
Neutrophils
Nucleated Rbc (Only Reported If Detected)
Platelet Count
Promyelocytes (Only Reported If Detected)
RDW
Reactive Lymphocytes (Only Reported If Detected)
Red Blood Cell Count
White Blood Cell Count
Also known as: Carcinoembryonic Antigen
Cea
Also known as: Chem 12, Chemistry Panel, Chemistry Screen, CMP, Complete Metabolic Panel, Comprehensive Metabolic Panel CMP, SMA 12, SMA 20
Albumin
Albumin/Globulin Ratio
Alkaline Phosphatase
Alt
AST
Bilirubin, Total
Bun/Creatinine Ratio
Calcium
Carbon Dioxide
Chloride
Creatinine
Egfr African American
Egfr Non-Afr. American
GFR-AFRICAN AMERICAN
GFR-NON AFRICAN AMERICAN
Globulin
Glucose
Potassium
Protein, Total
Sodium
Urea Nitrogen (Bun)
CYSTATIN C
eGFR
Also known as: Fecal Globin by Immunochemistry InSure, FOBT, InSure®, Occult Blood, Stool Blood, Stool Hemoglobin
Fecal Globin Result:
Ferritin
Also known as: Gamma Glutamyl Transferase GGT, Gamma-Glutamyl Transferase, Gamma-Glutamyl Transpeptidase, Gamma-GT, GGTP, GTP
Ggt
Also known as: A1c, Glycated Hemoglobin, Glycohemoglobin, Glycosylated Hemoglobin, HA1c, HbA1c, Hemoglobin A1c, Hemoglobin A1c HgbA1C, Hgb A1c
HEMOGLOBIN A1C
Also known as: Hepatitis Panel General
Confirmation
Hepatitis A Ab, Total
Hepatitis B Core Ab Total
Hepatitis B Surface
Hepatitis B Surface
Hepatitis C Antibody
Signal To Cut-Off
Also known as: C-Reactive Protein, Cardio CRP, Cardio hs-CRP, CRP, High Sensitivity CRP, High-sensitivity C-reactive Protein, High-sensitivity CRP, Highly Sensitive CRP, hsCRP, Ultra-sensitive CRP
Hs Crp
Also known as: Immunoglobulins Panel Serum
Immunoglobulin A
Immunoglobulin G
Immunoglobulin M
Also known as: Iron and TIBC, Iron and Total Iron Binding Capacity TIBC, TIBC
% Saturation
Iron Binding Capacity
Iron, Total
Also known as: Lactate Dehydrogenase LD, LDH
Ld
Also known as: Cholesterol, HDL,Fasting Lipids,Cholesterol, LDL, Fasting Lipids, Lipid Panel (fasting), Lipid Profile (fasting), Lipids
Chol/HDLC Ratio
Cholesterol, Total
HDL Cholesterol
LDL-Cholesterol
Non HDL Cholesterol
Triglycerides
Also known as: Fractionated PSA, Free PSA and Total PSA, Prostate Specific Antigen Free and Total, PSA Free and Total, PSA II
% Free Psa
Free Psa
Psa, Total
Vitamin D, 25-Oh, D2
Vitamin D, 25-Oh, D3
Vitamin D, 25-Oh, Total
Also known as: Thyroid Stimulating Hormone Test, Thyrotropin Test
TSH
Also known as: UA, Complete, Urinalysis UA Complete, Urine Analysis, Complete
Amorphous Sediment (Only Reported If Detected)
Appearance
Bacteria
Bilirubin
Calcium Oxalate Crystals (Only Reported If Detected)
Casts (Only Reported If Detected)
Color
Crystals (Only Reported If Detected)
Glucose
Granular Cast (Only Reported If Detected)
Hyaline Cast
Ketones
Leukocyte Esterase
Nitrite
Occult Blood
Ph
Protein
Rbc
Reducing Substances (Only Reported If Detected)
Renal Epithelial Cells (Only Reported If Detected)
Specific Gravity
Squamous Epithelial Cells
Transitional Epithelial (Only Reported If Detected)
Triple Phosphate Crystals (Only Reported If Detected)
Uric Acid Crystals (Only Reported If Detected)
WBC
YEAST (Only Reported If Detected)
The Preventive Health & Cancer Marker Lab Panel — Comprehensive Male panel contains 22 tests with 125 biomarkers .
Overview
The Preventive Health & Cancer Marker Lab Panel — Comprehensive Male is designed for men who want a broad lab-based review of preventive health markers along with selected cancer marker support tests that may be useful for physician-guided discussion.
This panel includes general wellness and prevention-related labs for blood health, liver function, kidney function, urine health, blood sugar, cholesterol, inflammation, iron status, thyroid function, vitamin D status, hepatitis screening, colorectal screening support, immune protein patterns, prostate marker support, and selected tumor markers.
This panel includes cancer marker support tests such as PSA Free and Total, AFP/AFP-L3, CEA, and CA 19-9. These markers should be interpreted carefully because tumor marker results are not diagnostic and are not a substitute for guideline-recommended cancer screening such as colonoscopy/FIT-based colorectal screening, PSA shared decision-making, lung cancer screening when appropriate, or other age- and risk-based screening. Abnormal results may occur for non-cancer reasons and should be reviewed with a licensed healthcare provider.
The National Cancer Institute notes that circulating tumor markers generally do not work well as stand-alone screening tests because they may lack sensitivity or specificity.
Why Order This Panel?
The Preventive Health & Cancer Marker Lab Panel — Comprehensive Male may be helpful for men who want a broad preventive wellness review with selected cancer marker support for provider-guided interpretation.
This panel may help provide insight into:
- Blood count patterns
- Liver and bile flow markers
- Kidney filtration and urine health
- Blood sugar and metabolic wellness
- Cholesterol and cardiovascular risk context
- Iron status and anemia-related patterns
- Inflammation
- Thyroid screening
- Vitamin D status
- Hepatitis-related liver risk context
- Colorectal screening support through fecal globin testing
- Prostate marker support with PSA free and total
- Immune protein patterns
- Selected cancer marker support tests for physician review
This panel is best positioned for customers who want a broad wellness and marker-support review while understanding that tumor markers are not stand-alone cancer screening or diagnostic tests.
This Panel May Be Helpful For Men Who Want To
- Review general preventive health biomarkers
- Check blood count, anemia, and iron-related markers
- Review liver, kidney, and urine health
- Evaluate blood sugar, cholesterol, and inflammation
- Check thyroid and vitamin D status
- Include stool-based colorectal screening support
- Review hepatitis-related liver risk markers
- Include PSA free and total for physician-guided prostate marker review
- Include selected cancer markers for physician-guided interpretation
- Discuss abnormal or borderline findings with a licensed healthcare provider
- Support a broader preventive wellness conversation
CDC supports guideline-recommended screening for breast, cervical, colorectal, and lung cancers, depending on age and risk. For men, this panel should be framed as preventive health and cancer marker support, not as a cancer diagnosis or stand-alone early cancer detection test.
Common Symptoms or Situations This Panel May Help Evaluate
This panel may be useful for men with or concerned about:
- General preventive health screening
- Fatigue or low energy
- Unexplained inflammation
- Abnormal liver enzymes
- Abnormal kidney markers
- Blood in stool screening concerns
- Prostate marker review
- Anemia or iron concerns
- Family history of cancer
- Hepatitis risk or liver risk concerns
- Metabolic syndrome risk
- Diabetes or prediabetes risk
- High cholesterol
- Thyroid-related symptoms
- Desire for a broad wellness and cancer marker support review
What This Panel Helps Evaluate
This panel helps evaluate selected biomarkers related to:
- Blood count and anemia-related patterns
- Liver function and bile flow
- Kidney function and urine health
- Cystatin C-based kidney filtration
- Urine albumin patterns
- Blood sugar and A1c
- Cholesterol and lipid patterns
- Inflammation
- Iron storage and iron availability
- Vitamin D status
- Thyroid screening
- Hepatitis screening
- Colorectal screening support
- Prostate marker support
- Immune proteins
- Broad tissue enzyme activity
- Selected tumor marker support for physician-guided review
Important Cancer Marker Interpretation Notice
Tumor marker results are not diagnostic and are not a substitute for guideline-recommended cancer screening such as colonoscopy/FIT-based colorectal screening, PSA shared decision-making, lung cancer screening when appropriate, or other age- and risk-based screening. Abnormal results may occur for non-cancer reasons and should be reviewed with a licensed healthcare provider.
For prostate cancer screening, the USPSTF states that men ages 55 to 69 should make an individual decision about PSA-based screening after discussing potential benefits and harms with a clinician, and recommends against routine PSA-based screening in men age 70 and older.
Tests Included and Why They Matter
Blood Health, Iron Status & General Wellness
CBC, includes Differential and Platelets
The CBC evaluates red blood cells, white blood cells, hemoglobin, hematocrit, platelets, and different types of white blood cells. This test is included because blood count patterns may provide context for anemia, infection, inflammation, immune activity, platelet changes, fatigue, and general wellness.
Ferritin
Ferritin measures stored iron. This test is included because ferritin may provide context for iron storage, anemia-related patterns, inflammation, liver/metabolic patterns, and fatigue-related concerns.
Iron and Total Iron Binding Capacity, TIBC
Iron and TIBC help evaluate circulating iron and iron transport capacity. This test is included because iron deficiency, iron overload, or abnormal iron availability may provide useful context for anemia, fatigue, liver health, and inflammation.
Liver Function, Bile Flow & Hepatitis-Related Risk Context
Comprehensive Metabolic Panel, CMP
The CMP evaluates glucose, liver function, kidney function, electrolytes, calcium, albumin, total protein, and other metabolic markers. It includes important liver and kidney markers such as AST, ALT, alkaline phosphatase, bilirubin, creatinine, BUN, and electrolytes.
Gamma Glutamyl Transferase, GGT
GGT is a liver and bile duct enzyme. This test is included because it may provide useful context for liver stress, bile flow, alcohol exposure, fatty liver patterns, medication use, supplement use, and metabolic liver health.
Bilirubin, Fractionated
Fractionated bilirubin measures total, direct, and indirect bilirubin. This test is included because bilirubin patterns can provide more detailed context for liver processing, bile flow, red blood cell breakdown, and bilirubin metabolism than direct bilirubin alone.
Hepatitis Panel, General
The Hepatitis Panel, General is included because hepatitis status may be relevant to liver health and liver cancer risk context. Hepatitis-related findings should be reviewed with a healthcare provider, especially if results suggest prior exposure, current infection, or need for follow-up.
Alpha-Fetoprotein, AFP and AFP-L3
AFP and AFP-L3 are cancer marker support tests often discussed in liver-risk contexts. This test is included because AFP-related markers may provide physician-guided liver marker context, especially when reviewed with hepatitis status, liver enzymes, imaging history, and risk factors.
Kidney, Urine & Vascular Health Support
Cystatin C with eGFR
Cystatin C with eGFR provides an additional way to evaluate kidney filtration. This test is included because cystatin C may provide useful kidney function context beyond creatinine alone, especially when muscle mass or other factors may affect creatinine interpretation.
Albumin, Random Urine with Creatinine
This urine test evaluates albumin in relation to creatinine. It is included because urine albumin may provide early kidney and vascular health context, especially in people with diabetes risk, high blood pressure, kidney stress, or metabolic health concerns.
Urinalysis, UA, Complete
A complete urinalysis evaluates urine markers such as protein, blood, glucose, ketones, specific gravity, pH, and other findings. This test is included because urine findings may provide context for kidney health, hydration, urinary tract findings, glucose handling, and blood or protein in urine.
Metabolic, Cardiovascular & Inflammation Support
Hemoglobin A1c
Hemoglobin A1c measures average blood sugar over approximately the past two to three months. This test is included because blood sugar patterns may provide useful context for diabetes risk, metabolic health, kidney risk, cardiovascular wellness, and preventive health.
Lipid Panel
The Lipid Panel measures total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. This test is included because cholesterol and triglyceride patterns are important for cardiovascular and metabolic wellness.
hs-CRP
High-sensitivity C-reactive protein is a marker of low-grade inflammation. This test is included because inflammation may provide useful context for cardiometabolic risk, liver/metabolic health, ferritin interpretation, and general wellness.
Lactate Dehydrogenase, LD
LD is a broad tissue enzyme marker. This test is included because it may provide general tissue injury or cell turnover context, although it is nonspecific and should be interpreted with other results and clinical history.
Thyroid & Vitamin D Wellness
TSH
TSH, or thyroid-stimulating hormone, is a key thyroid screening marker. This test is included because thyroid function may influence energy, metabolism, weight, mood, bowel habits, hair, skin, and overall wellness.
QuestAssureD™ 25-Hydroxyvitamin D, D2, D3, LC/MS/MS
Vitamin D testing measures vitamin D status. This test is included because vitamin D may be relevant to bone health, immune health, muscle function, inflammation, and general preventive wellness.
Colorectal Screening Support
Fecal Globin by Immunochemistry, InSure®
Fecal globin by immunochemistry helps evaluate for hidden blood in stool. This test is included because stool blood testing can support colorectal screening discussions. An abnormal fecal blood result should be reviewed promptly with a healthcare provider and may require follow-up evaluation, such as colonoscopy.
CDC notes that adults ages 45 to 75 should be screened for colorectal cancer, with individualized decisions for older adults.
Prostate Marker Support
PSA, Free and Total
PSA Free and Total provides prostate marker context. PSA may be discussed as part of shared decision-making for prostate cancer screening in appropriate men based on age, symptoms, personal history, family history, and risk factors.
Free PSA can provide additional context when total PSA is elevated or borderline. PSA results should not be interpreted in isolation and should be reviewed with a licensed healthcare provider.
Immune Protein Pattern Support
Immunoglobulins Panel, Serum
The immunoglobulins panel evaluates immune proteins such as IgG, IgA, and IgM. This test is included because immunoglobulin patterns may provide immune system and protein-pattern context that can be useful in broader preventive health review.
Cancer Marker Support Tests
CA 19-9
CA 19-9 is a tumor marker often discussed in pancreatic, biliary, and gastrointestinal contexts. It is included as a cancer marker support test for physician-guided review. CA 19-9 can be elevated in non-cancer conditions and should not be used as a stand-alone cancer screening test.
CEA
CEA is a tumor marker often discussed in colorectal and other cancer monitoring contexts. It is included as a cancer marker support test for physician-guided interpretation. CEA can be elevated for non-cancer reasons and is not a stand-alone screening or diagnostic test.
Related Biomarker Patterns This Panel May Help Identify
This panel may help identify or rule out lab patterns related to:
- Blood count abnormalities
- Anemia or iron-related concerns
- Liver enzyme and bile flow patterns
- Hepatitis-related liver risk context
- Kidney filtration and urine findings
- Urine albumin patterns
- Blood sugar imbalance
- Cholesterol or triglyceride abnormalities
- Low-grade inflammation
- Vitamin D status
- Thyroid screening abnormalities
- Hidden blood in stool
- PSA patterns requiring physician review
- Immune protein patterns
- Selected tumor marker elevations requiring physician-guided review
How to Prepare for This Panel
Preparation may vary depending on the specific tests included and instructions provided with your order. In general:
- Fasting may be recommended because this panel includes glucose-related and lipid markers.
- Follow stool collection instructions carefully for the fecal globin/InSure® test.
- Drink water before your blood draw unless instructed otherwise.
- Do not overhydrate immediately before urine testing unless instructed.
- Continue medications unless your healthcare provider tells you otherwise.
- Bring or keep a list of medications, supplements, personal cancer history, family cancer history, screening history, prostate history, urinary symptoms, and recent imaging or procedures to discuss during your physician consultation.
- Follow all lab collection instructions provided with your order.
What Happens After You Receive Your Results?
After your results are available, your biomarkers can help organize findings into areas such as blood health, liver function, kidney and urine health, blood sugar, lipids, inflammation, thyroid screening, vitamin D status, colorectal screening support, hepatitis status, prostate marker support, immune protein patterns, and selected cancer marker support results.
During the physician consultation, you can discuss what your results may mean, whether follow-up testing is appropriate, and what guideline-recommended cancer screenings may be relevant based on your age, symptoms, personal history, family history, prostate history, and risk factors.
Related Lab Panels
Customers interested in this panel may also consider:
- Preventive Health & Cancer Marker Lab Panel — Comprehensive Female
- Heart Health & Cholesterol Lab Panel
- Longevity & Healthy Aging Lab Panel
- Kidney, Liver & Detox Support Lab Panel
- Vitamin, Mineral & Nutrient Deficiency Lab Panel
- Inflammation, Autoimmune & Chronic Pain Lab Panel
- Men’s Testosterone, Energy & Vitality Lab Panel
- Heavy Metals & Environmental Toxins Lab Panel
Frequently Asked Questions
What is the Preventive Health & Cancer Marker Lab Panel — Comprehensive Male?
It is a broad preventive health and cancer marker support panel for men. It evaluates selected biomarkers related to blood health, liver function, kidney function, blood sugar, cholesterol, inflammation, thyroid function, vitamin D, stool blood screening support, hepatitis status, prostate marker support, immune protein patterns, and selected tumor markers.
Does this panel diagnose cancer?
No. This panel does not diagnose cancer. Tumor markers are not stand-alone cancer screening or diagnostic tests. Abnormal results may occur for non-cancer reasons and should be reviewed with a licensed healthcare provider.
Are tumor markers a substitute for colonoscopy, FIT screening, PSA shared decision-making, or lung cancer screening?
No. Tumor markers are not a substitute for guideline-recommended cancer screening such as colonoscopy/FIT-based colorectal screening, PSA shared decision-making, lung cancer screening when appropriate, or other age- and risk-based screening.
Why are PSA Free and Total included?
PSA Free and Total is included to provide prostate marker support for physician-guided review. PSA screening decisions should be individualized based on age, risk factors, symptoms, and a discussion of benefits and harms with a clinician.
Why are CA 19-9, CEA, and AFP included?
These are included as cancer marker support tests for physician-guided interpretation. They may provide additional context in selected situations but should not be used alone to screen for or diagnose cancer.
Why is Fecal Globin by Immunochemistry included?
Fecal globin testing helps evaluate hidden blood in stool and may support colorectal screening discussions. Abnormal results should be reviewed with a provider and may require follow-up evaluation.
Why is the hepatitis panel included?
The hepatitis panel may provide liver health and liver-risk context. Certain hepatitis infections can affect long-term liver health and may require provider follow-up.
What should I do if a tumor marker is abnormal?
Review the result with a licensed healthcare provider. Follow-up may depend on symptoms, age, personal history, family history, screening history, imaging results, medication use, inflammation, liver function, kidney function, and other risk factors.
Important Note
Tumor marker results are not diagnostic and are not a substitute for guideline-recommended cancer screening such as colonoscopy/FIT-based colorectal screening, PSA shared decision-making, lung cancer screening when appropriate, or other age- and risk-based screening. Abnormal results may occur for non-cancer reasons and should be reviewed with a licensed healthcare provider.
This panel is designed to support preventive health and physician-guided cancer marker review. It is not intended to diagnose, treat, cure, prevent, or definitively screen for cancer or any disease by itself.